Locally secreted Fc-OX40L is superior to systemic, antibody mediated, OX40 costimulation for combination immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent: 2 patents

Readers on

mendeley: 7 Mendeley

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

COMBINATION CELL-BASED THERAPIES

Application EP-3860647-A4

European Patent Office

TREATMENT OF CANCER WITH SMG1-INHIBITORS

Application WO-2018152095-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.